St. John Fisher College can serve as an example to colleges everywhere in being proactive to protect students with severe allergies. They are stocking epinephrine throughout the campus and conducting training sessions for security, health care personnel and resident assistants. As the college had three incidences of anaphylaxis last year alone, we are very proud to help in this important endeavor.
Local College Implements New York’s Emergency Allergy Treatment Act
By Janet Goldman February 10th, 2018
St. John Fisher College is becoming a role model for local colleges and other public entities in western New York. As authorized by New York’s Emergency Allergy Treatment Act (EATA), the College is stocking epinephrine, making it available for students, staff and visitors as needed. With a non-specific epinephrine prescription, specifically trained College staff will be able to administer epinephrine to anyone suffering from anaphylaxis.
After a prolonged struggle Wisconsin residents Angel and George Mueller succeeded in their tireless efforts to enact legislation allowing trained and certified individuals to carry and administer epinephrine in case of an attack of anaphylaxis. Be Strong and BRRAAPP ON! Read the article Epinephrine commonly administered by unlicensed school staff.
Our founder, Jon Terry, attended the USAnaphylaxis Summit held in Washington, DC, sponsored by the Allergy and Asthma Network. He came away with some great information to share from leading experts in the field who identified best practices and helped develop call-to-action strategies. Jon believes some great strides are being made in anaphylaxis prevention.
This past fall I attended the USAnaphylaxis Summit meeting at the National Harbor outside of Washington, DC. The event was sponsored by the Allergy and Asthma Network, for over thirty years the leading national nonprofit organization dedicated to ending needless death and suffering due to asthma, allergies and related conditions. Five years ago, AAN invited a small group of stakeholders to Washington, DC to participate in the first USAnaphylaxis Summit and hear from leading experts, identify best practices and develop call-to-action strategies. This year the Network gathered experts in allergies, anaphylaxis and patient care to collaborate and author a journal article based on the Summit’s presentations.
A study by Dr. Michael Pistiner of MassGeneral Hospital for Children found that epinephrine was often administered in schools by nonmedical staff, and sometimes to students with no known allergy. This reinforces the importance of legislation such as the Nurse Authorized Stock Epinephrine laws and the training of ALL school personnel. This is especially important for schools that do not have full-time nurses.
CHICAGO — As many as one in five anaphylactic events among children without known allergies are treated with epinephrine administered by an unlicensed school nurse or staff member, according to a recent presentation at the American Academy of Pediatrics 2017 National Conference & Exhibition.
We are very grateful for the leadership role Assemblyman David Buchwald (D-Westchester) and Senator Terence Murphy (R-Westchester) took in helping to pass legislation permitting school bus drivers and other school service providers to administer epinephrine in an emergency. And many thanks go to Gov. Andrew Cuomo for signing the bill so promptly. Now it is up to the New York State Department of Health to move quickly to issue the regulations necessary for timely implementation. We sincerely believe this legislation will help to save many lives over the years. You can read the full article here.
Allows Drivers and Others to Administer Life Saving Epinephrine
Adapted from a press release issued by Assemblyman David Buchwald with additional reporting by Jon Terry August 22, 2017
Governor Andrew Cuomo has signed legislation sponsored by Assemblyman David Buchwald (D-Westchester) to allow school bus drivers and other contractors providing services to schools to administer epinephrine when a child suffers anaphylaxis shock.